00006-5033
Ontruzant
Trastuzumab
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
TRASTUZUMAB
150.0
mg/1
00006-5033-02
1 VIAL, SINGLE-DOSE in 1 CARTON (0006-5033-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0006-5033-01)
April 15, 2020
Sept. 30, 2023
Immunotherapy
Monoclonal Antibody
HER2
 
In Use